News und Analysen
Neogen Q4 Earnings Call Highlights
Key Points
- Interested in Neogen Corporation? Here are five stocks we like better.
- Q4 performance improved: Neogen reported $225.3 million in revenue, with core growth accelerating to 4.3%. Food
Multibeam unterzeichnet Absichtserklärung über Förderung von 140 Mio. USD mit US-Handelsministerium
Absichtserklärung ebnet den Weg für eine strategische Initiative zur Entwicklung von Fine-Pitch-Prozessabläufen für die energieeffiziente heterogene Chipintegration der nächsten Generation
Multibeam unterzeichnet Absichtserklärung über Förderung von 140 Mio. USD mit US-Handelsministerium
Absichtserklärung ebnet den Weg für eine strategische Initiative zur Entwicklung von Fine-Pitch-Prozessabläufen für die energieeffiziente heterogene Chipintegration der nächsten Generation
EQS-News: NanoRepro AG: Jahresabschluss 2025 veröffentlicht – Gruppe mit konsolidiertem Umsatz von rund 16 Mio. EUR auf Wachstumskurs
EQS-News: NanoRepro AG: Jahresabschluss 2025 veröffentlicht – Gruppe mit konsolidiertem Umsatz von rund 16 Mio. EUR auf Wachstumskurs
The Hanover Insurance Group Q2 Earnings Call Highlights
The Hanover Insurance Group (NYSE:THG) reported record second-quarter operating performance, citing improved underwriting margins, accelerating premium growth and higher investment income across
London Stock Exchange Group H1 Earnings Call Highlights
Key Points
- Interested in London Stock Exchange Group plc? Here are five stocks we like better.
- LSEG delivered strong first-half results: Organic revenue grew 8.4%, adjusted EBITDA rose 14%
EQS-News: MEDICLIN beendet solides erstes Halbjahr 2026
EQS-News: MEDICLIN beendet solides erstes Halbjahr 2026
Robert Walters H1 Earnings Call Highlights
Robert Walters (LON:RWA) said its first-half 2026 performance was in line with expectations as the recruitment firm reduced costs, continued cash-management actions and reported improving trends in
Penske Automotive Group Q2 Earnings Call Highlights
Key Points
- Interested in Penske Automotive Group, Inc.? Here are five stocks we like better.
- Second-quarter revenue rose 6% to $8.5 billion, with adjusted EPS of $3.62 excluding
Orion Group Q2 Earnings Call Highlights
Key Points
- Interested in Orion Group Holdings, Inc.? Here are five stocks we like better.
- Second-quarter results weakened due to marine project delays: Revenue rose 8% to $222 million, but lower
EQS-News: Drägerwerk AG & Co. KGaA: Dräger mit starker Geschäftsentwicklung im ersten Halbjahr 2026
EQS-News: Drägerwerk AG & Co. KGaA: Dräger mit starker Geschäftsentwicklung im ersten Halbjahr 2026
Humana Q2 Earnings Call Highlights
Key Points
- Interested in Humana Inc.? Here are five stocks we like better.
- Humana expects 2027 Medicare Advantage margin expansion to keep it on track for a sustainable pretax margin of at least
Glaukos Q2 Earnings Call Highlights
Key Points
- Interested in Glaukos Corporation? Here are five stocks we like better.
- Record Q2 sales: Glaukos reported $185.6 million in second-quarter revenue, up 50% year over year, driven by
CONMED Q2 Earnings Call Highlights
Key Points
- Interested in CONMED Corporation? Here are five stocks we like better.
- CONMED delivered better-than-expected Q2 results: Organic sales rose 6%, adjusted EPS increased 20% to $1.38
Bausch Health Cos Q2 Earnings Call Highlights
Key Points
- Interested in Bausch Health Cos Inc.? Here are five stocks we like better.
- Bausch Health raised its full-year outlook after reporting strong second-quarter growth: excluding Bausch +
Viking Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Viking Therapeutics, Inc.? Here are five stocks we like better.
- Viking’s losses widened as it increased investment in its obesity pipeline: Q2 net loss reached $128.1
Tenable Q2 Earnings Call Highlights
Key Points
- Interested in Tenable Holdings, Inc.? Here are five stocks we like better.
- Tenable exceeded Q2 guidance and raised its full-year outlook. Revenue rose 8.6% year over year to $268.5
MannKind’s Inhaled IPF Drug Clears Phase 1b Safety Hurdle, Phase 2 Underway
Key Points
- Interested in MannKind Corporation? Here are five stocks we like better.
- MannKind’s Phase 1b trial met its short-term safety and tolerability objective in 27 IPF patients, with no
MiMedx Group Q2 Earnings Call Highlights
Key Points
- Interested in MiMedx Group, Inc? Here are five stocks we like better.
- MiMedx agreed to acquire Sanara MedTech for $35 per share, adding more than $100 million in surgical revenue and
Corcept Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Corcept Therapeutics Incorporated? Here are five stocks we like better.
- Second-quarter revenue rose 32% to $256.1 million, driven by growth in the Cushing’s syndrome
Align Technology Q2 Earnings Call Highlights
Key Points
- Interested in Align Technology, Inc.? Here are five stocks we like better.
- Record Q2 revenue reached $1.06 billion, up 4.3% year over year, driven by an 8.2% increase in clear
Crane Q2 Earnings Call Highlights
Key Points
- Interested in Crane? Here are five stocks we like better.
- Record Q2 performance: Crane reported 26% sales growth, 37% adjusted operating-profit growth and a record 21.3% adjusted
Europäische Kommission genehmigt Marktzulassung des an XFG angepassten COVID-19-Impfstoffs von Pfizer und BioNTech in der Europäischen Union
- Daten zeigten, dass die COVID-19-Impfstoffformulierung für das Jahr 2026-2027, die gegen die XFG-Variante gerichtet ist, eine starke Immunantwort gegen derzeit zirkulierende und neu auftretende
Europäische Kommission genehmigt Marktzulassung des an XFG angepassten COVID-19-Impfstoffs von Pfizer und BioNTech in der Europäischen Union
- Daten zeigten, dass die COVID-19-Impfstoffformulierung für das Jahr 2026-2027, die gegen die XFG-Variante gerichtet ist, eine starke Immunantwort gegen derzeit zirkulierende und neu auftretende
Chemed Q2 Earnings Call Highlights
Key Points
- Interested in Chemed Corporation? Here are five stocks we like better.
- Chemed delivered strong Q2 results: Consolidated revenue increased 8.8% year over year, adjusted diluted EPS